Showing papers by "Michel Farnier published in 1991"

TL;DR: It is shown in rats, that a specific feature of the lipid-lowering drug gemfibrozil is its effect on plasma apolipoprotein E (apo El level and distribution), and no other fibric acid derivative induces such alterations in plasma apo E concentrations.